RELYPSA
Relypsa, Inc. is a privately-held, development stage biopharmaceutical company leading the discovery and development of novel non-absorbed polymeric drugs for important applications in cardiovascular and renal disease. Relypsa's lead product candidate is RLY5016, a non-absorbed potassium binder for the management of hyperkalemia. Relypsa is dedicated to discover additional product candidates through use of its proprietary polymer platform.
RELYPSA
Social Links:
Industry:
Biopharma Biotechnology Health Care
Founded:
2007-10-01
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.relypsa.com
Total Employee:
501+
Status:
Closed
Contact:
(650) 421-9500
Email Addresses:
[email protected]
Total Funding:
656.63 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Domain Not Resolving Mobile Non Scaleable Content Microsoft Azure DNS DigiCert SSL ASP.NET 4.0 ASP.NET Ajax RapidSSL
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Relypsa
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Relypsa
OrbiMed
OrbiMed investment in Venture Round - Relypsa
5AM Ventures
5AM Ventures investment in Venture Round - Relypsa
New Leaf Venture Partners
New Leaf Venture Partners investment in Venture Round - Relypsa
New Leaf Venture Partners
New Leaf Venture Partners investment in Series C - Relypsa
Delphi Ventures
Delphi Ventures investment in Series C - Relypsa
Sibling Capital
Sibling Capital investment in Series C - Relypsa
Sprout Group
Sprout Group investment in Series C - Relypsa
Mediphase Venture Partners
Mediphase Venture Partners investment in Series C - Relypsa
Official Site Inspections
http://www.relypsa.com
- Host name: ewhserver1302.edgewebhosting.net
- IP address: 69.63.140.80
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago